Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells

Cell Death and Disease

Volumn 4, Issue 8, 2013, Pages

  Chimento, A ^a   Casaburi, I ^a   Bartucci, M ^b   Patrizii, M ^b   Dattilo, R ^b   Avena, P ^a   Ando S ^a   Pezzi, V ^a   Sirianni, R ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Apoptosis; GPER; Leydig cell tumor

Indexed keywords

CASPASE; CISPLATIN; CYTOCHROME C; DNA; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME RELEASE; GENE SILENCING; IN VIVO STUDY; LEYDIG CELL; MALE; MITOCHONDRION; MORPHOLOGY; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TESTIS FUNCTION; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 84882575417     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.275     Document Type: Article

References (59)

1. Ahmed HU, Arya M, Muneer A, Mushtaq I, Sebire NJ. Testicular and paratesticular tumours in the prepubertal population. Lancet Oncol 2010; 11: 476-483
2. Mü ller J, Skakkebæk NE. Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int J Androl 1983; 6: 143-156
3. de Rooij DG, van de Kant HJG, Dol R, Wagemaker G, van Buul PPW, van Duijn-Goedhart A et al. Long-Term effects of irradiation before adulthood on reproductive function in the male rhesus monkey. Biol Reprod 2002; 66: 486-494 (Pubitemid 34101848)
4. Sawhney P, Giammona CJ, Meistrich ML, Richburg JH. Cisplatin-induced long-Term failure of spermatogenesis in adult C57/Bl/6J mice. J Androl 2005; 26: 136-145 (Pubitemid 39665287)
5. ÓDonnell L, Robertson KM, Jones ME, Simpson ER. Estrogen and spermatogenesis. Endocr Rev 2001; 22: 289-318 (Pubitemid 32554361)
6. Sharpe RM. The 'oestrogen hypothesis'-where do we stand now? Int J Androl 2003; 26: 2-15
7. Li X, Nokkala E, Yan W, Streng T, Saarinen N, Warri A et al. Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 2001; 142: 2435-2442 (Pubitemid 32475760)
8. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J et al. Estrogen receptors: How do they signal and what are their targets. Physiol Rev 2007; 87: 905-931 (Pubitemid 47084672)
9. Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab 2009; 20: 477-482
10. Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 2010; 204: 105-114
11. Lappano R, De Marco P, De Francesco EM, Chimento A, Pezzi V, Maggiolini M. Cross-Talk between GPER and growth factor signaling. J Steroid Biochem Mol Biol 2013 pii S0960-0760: 00054-X.
12. Carreau S, Chimento A, Bois C, Sirianni R, Delalande C, Pezzi V. Rapid estrogen signaling in spermatogenesis. Immunol Endocr Metab Agentsn Med Chem 2011; 11: 294-305
13. Bois C, Delalande C, Nurmio M, Parvinen M, Zanatta L, Toppari J et al. Age-And cell-related gene expression of aromatase and estrogen receptors in the rat testis. J Mol Endocrinol 2010; 45: 147-159
14. Akingbemi B. Estrogen regulation of testicular function. Reprod Biol Endocrinol 2005; 3: 51-63
15. Carpino A, Rago V, Pezzi V, Carani C, Ando S. Detection of aromatase and estrogen receptors (ER{alpha}, ER{beta}1, ER{beta}2) in human Leydig cell tumor. Eur J Endocrinol 2007; 157: 239-244 (Pubitemid 47233131)
16. Sirianni R, Chimento A, Malivindi R, Mazzitelli I, Ando S, Pezzi V. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation. Cancer Res 2007; 67: 8368-8377 (Pubitemid 47395176)
17. Chumsri S, Howes T, Bao T, Sabnis G, Brodie A. Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol 2011; 125: 13-22
18. Massoner P, Ladurner-Rennau M, Eder IE, Klocker H. Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer. Br J Cancer 2010; 103: 1479-1484
19. Haluska P, Worden F, Olmos D, Yin D, Schteingart D, Batzel GN et al. Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma. Cancer Chemother Pharmacol 2010; 65: 765-773
20. Rago V, Romeo F, Giordano F, Maggiolini M, Carpino A. Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes. Reprod Biol Endocrinol 2011; 9: 135
21. Lucas TsFG, Royer C, Siu ER, Lazari MF, Porto CS. Expression and signaling of g protein-coupled estrogen receptor 1 (GPER) in rat Sertoli cells. Biol Reprod 2010; 83: 307-317
22. Franco R, Boscia F, Gigantino V, Marra L, Esposito F, Ferrara D et al. GPR30 is overexpressed in post-puberal testicular germ cell tumors. Cancer Biol Ther 2011; 11: 609-613
23. Chevalier N, Bouskine A, Fenichel P. Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30. Int J Cancer 2012; 130: 241-242
24. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz ER, Cappello AR et al. G-protein-coupled receptor 30 and estrogen receptor-Alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ Health Perspect 2008; 116: 1648-1655
25. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Ando S et al. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17betaestradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 2006; 20: 631-646 (Pubitemid 43291214)
26. Chan QKY, Lam HM, Ng CF, Lee AYY, Chan ESY, Ng HK et al. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest. Cell Death Differ 2010; 17: 1511-1523
27. Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE et al. The G proteincoupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res 2010; 70: 1184-1194
28. Sirianni R, Chimento A, Ruggiero C, De Luca A, Lappano R, Ando S et al. The novel estrogen receptor, g protein-coupled receptor 30, mediates the proliferative effects induced by 17{beta}-estradiol on mouse spermatogonial GC-1 cell line. Endocrinology 2008; 149: 5043-5051
29. 2. J Biol Chem 1997; 272: 10882-10894
30. Oberst A, Bender C, Green DR. Living with death: The evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ 2008; 15: 1139-1146 (Pubitemid 351850966)
31. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776
32. Soldani C, Scovassi AI. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update. Apoptosis 2002; 7: 321-328 (Pubitemid 34832256)
33. Chen J-R, Plotkin LI, Aguirre JI, Han L, Jilka RL, Kousteni S et al. Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-Apoptotic effects of estrogens. J Biol Chem 2005; 280: 4632-4638 (Pubitemid 40288632)
34. Fung C, Vaughn DJ. Complications associated with chemotherapy in testicular cancer management. Nat Rev Urol 2011; 8: 213-222
35. Montanaro D, Maggiolini M, Recchia AG, Sirianni R, Aquila S, Barzon L et al. Antiestrogens upregulate estrogen receptor {beta} expression and inhibit adrenocortical H295R cell proliferation. J Mol Endocrinol 2005; 35: 245-256 (Pubitemid 41556173)
36. Lin BC, Suzawa M, Blind RD, Tobias SC, Bulun SE, Scanlan TS et al. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res 2009; 69: 5415-5423
37. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A et al. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17{beta}-estradiol and selective GPR30 ligand g-1 in ovarian cancer cells. Cancer Res 2007; 67: 1859-1866 (Pubitemid 46383413)
38. Ekena K, Katzenellenbogen JA, Katzenellenbogen BS. Determinants of ligand specificity of estrogen receptor-A: Estrogen versus androgen discrimination. J Biol Chem 1998; 273: 693-699 (Pubitemid 28049154)
39. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2006; 2: 207-212
40. Pais V, Leav I, Lau K-M, Jiang Z, Ho S-M. Estrogen receptor-b expression in human testicular germ cell tumors. Clin Cancer Res 2003; 9: 4475-4482 (Pubitemid 37248406)
41. Rago V, Romeo F, Giordano F, Ferraro A, Ando S, Carpino A. Identification of ERbeta1 and ERbeta2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia. Reprod Biol Endocrinol 2009; 7: 56
42. Guido C, Panza S, Santoro M, Avena P, Panno ML, Perrotta I et al. Estrogen receptor beta (ERb) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle 2012; 11: 2911-2921
43. Kim R, Emi M, Tanabe K, Murakami S, Uchida Y, Arihiro K. Regulation and interplay of apoptotic and non-Apoptotic cell death. J Pathol 2006; 208: 319-326 (Pubitemid 43210518)
44. Fadeel B, Orrenius S. Apoptosis: A basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 2005; 258: 479-517 (Pubitemid 41705391)
45. Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2: 647-656 (Pubitemid 37328916)
46. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 2000; 345: 271-278 (Pubitemid 30077167)
47. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15: 2922-2933 (Pubitemid 33078942)
48. Kuida K, Haydar TF, Kuan C-Y, Gu Y, Taya C, Karasuyama H et al. Reduced apoptosis and cytochrome c mediated caspase activation in mice lacking caspase 9. Cell 1998; 94: 325-337 (Pubitemid 28376077)
49. Wilson MR. Apoptosis: Unmasking the executioner. Cell Death Differ 1998; 5: 646-652 (Pubitemid 28391366)
50. Adachi T, Kar S, Wang M, Carr BI. Transient and sustained ERK phosphorylation and nuclear translocation in growth control. J Cell Physiol 2002; 192: 151-159 (Pubitemid 34747783)
51. Chimento A, Sirianni R, Delalande C, Silandre D, Bois C, Andò S et al. 17b-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ERa. Mol Cell Endocrinol 2010; 320: 136-144
52. Chimento A, Sirianni R, Zolea F, Bois C, Delalande C, Ando S et al. Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax. Int J Androl 2011; 34(5 Pt 1): 420-429
53. Chimento A, Sirianni R, Casaburi I, Ruggiero C, Maggiolini M, Ando S et al. 17Beta-estradiol activates GPER-And ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line. Mol Cell Endocrinol 2012; 355: 49-59
54. Appenroth D, Winnefeld K, Braunlich H. Nephrotoxicity and pharmacokinetics of cisplatinum in young and adult rats. Biomed Biochim Acta 1988; 47: 791-797
55. Thompson SW, Davis LE, Kornfeld M, Hilgers RD, Standefer JC. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 1984; 54: 1269-1275 (Pubitemid 14003522)
56. Drasga RE, Einhorn LH, Williams SD, Patel DN, Stevens EE. Fertility after chemotherapy for testicular cancer. J Clin Oncol 1983; 1: 179-183 (Pubitemid 14245663)
57. Meistrich ML, Finch M, da Cunha MF, Hacker U, Au WW. Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res 1982; 42: 122-131 (Pubitemid 12207259)
58. Sirianni R, Chimento A, De Luca A, Zolea F, Carpino A, Rago V et al. Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells. J Biol Chem 2009; 284: 28905-28916
59. Sirianni R, Zolea F, Chimento A, Ruggiero C, Cerquetti L, Fallo F et al. Targeting estrogen receptor-Alpha reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment. J Clin Endocrinol Metab 2012; 97: E2238-E2250